In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

From crippling fatigue to brain fog, CML treatment can affect your body in ways that go beyond the usual side effects.

Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...

Feb. 5. 2025 – The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL). This treatment is for people who are newly diagnosed or haven't ...

Inc. (Market cap: $34.46M) has reported its financial performance for the fourth quarter of 2023, highlighting a steady cash flow and strategic advancements in its clinical pipeline. According to ...

Saeed Sadeghi, MD, discusses treatment options in low-risk myelodysplastic syndrome at a Case-Based Roundtable event.

TOXICITY from nitrous oxide has been assumed to be entirely the effect of associated reduction of oxygen tension. Goldman, 1 in 1928, reported the intermittent administration of nitrous oxide to ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) patients with a new all-tablet treatment showing impressive results.

and patients were counted a maximum of once per discontinuation reason and could have been counted under multiple discontinuation reasons. CLL denotes chronic lymphocytic leukemia.

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his life by 30 years.

O’Neil, 35, was transferred to Maine Medical Center, where further tests showed that she has acute myeloid leukemia, a cancer of the blood and bone marrow. Often referred to as AML, it is the ...

The chimeric BCR–ABL oncoprotein is the molecular hallmark of chronic myelogenous leukemia (CML). BCR–ABL contains nuclear import and export signals but it is localized only in the cytoplasm ...